Mets Mailbag: Skubal, The Bullpen Depth Chart, and Free Agency Chaos

New York Mets · 2026-11-13 · Beatline Sports Podcast Network

Sarah: If you think the New York Mets are done shaking up their rotation, you haven’t been paying attention. We’re talking about a potential blockbuster signing that could completely redefine this pitching staff, plus a look at a bullpen that is deeper than almost anyone expected coming out of spring training last year.

Tom: It’s wild how much the landscape has shifted in just three days. We’ve got answers for your questions on Tarik Skubal, the catching situation with Francisco Alvarez and Luis Torrens, and where Bo Bichette fits into the infield hierarchy now that he’s on the roster.

Sarah: Welcome to the Beatline Podcast Network, America’s number one daily sports podcast network. I’m Sarah, and alongside me as always is our lead analyst, Tom. Good morning, everyone, and welcome back to the daily mailbag edition where we tackle your questions head-on.

Tom: Good morning, Sarah. It is great to be here. We have a packed show today because the headlines from ESPN are moving fast. We’ve got the Skubal meeting, we’ve got the Robert Stock re-signing, and we’ve got a lot of questions from you guys about how all these pieces fit together for the 2027 season.

Sarah: That’s right. So here is what we are tackling today. First, we dive deep into the pursuit of Tarik Skubal and whether adding an ace like him makes sense given the current roster construction. Second, we break down the depth chart battles, specifically at catcher and in the infield with new acquisitions. And third, we’ll hit some fun hypotheticals and quick takes before we wrap up. Let’s get into it.

Sarah: Okay, let’s start with the biggest headline in baseball right now. Marcus in Denver asks: "The reports say the Mets are scheduled to meet with prized ace Tarik Skubal next week in California. Given the team finished with a 74-88 record last year but still won the division, do they really need to spend big money on another starter?"

Tom: That is such a good question, Marcus. On paper, winning the NL East with a losing record suggests the rest of the division was terrible. But if you look at the rotation, it’s not exactly a fortress. You have Sean Manaea, Tylor Megill, Nolan McLean, Christian Scott, Zac Thornton, Jonah Tong, and Robert Stock. It’s a group that relies heavily on health and variance.

Sarah: Right, because 'variance' is a polite way of saying 'we don't know who's going to pitch effectively every fifth day.' So why would the front office go after Skubal? He’s the prize of the free agent class. Isn't that a luxury they can't afford?

Tom: It’s not about affordability; it’s about ceiling. If you want to turn those 74 wins into 95, you need a true #1 arm who can eat innings and suppress contact. Skubal brings elite strikeout rates and dominant stuff. If the Dodgers and Mets are both in on him, it means his agent sees value in New York’s market and financial flexibility. It’s a high-risk, high-reward move.

Sarah: And remember, Jeff Passan mentioned earlier this week that teams needing an ace should watch this closely. The Mets aren't just looking for any starter; they’re looking for stability. What about the other side of the coin? @SaltyCatcher writes in: "I’m worried about the bullpen. With Kodai Senga listed as a reliever now, does that mean he’s no longer a starter?"

Tom: Yes, it absolutely does. The roster list clearly puts Kodai Senga in the RP column. This is a massive shift. Senga was a frontline starter in Japan and had moments here, but moving him to the bullpen opens up a rotation spot for someone else—maybe a call-up or a trade target—and gives the manager a devastating weapon in late innings. It changes the entire tactical approach to closing games.

Sarah: So instead of worrying about who starts Game 4, we’re worrying about who faces the cleanup hitters in the ninth. That’s a huge strategic change. Devin Williams is already there, and now Senga? That’s a scary top of the relief corps. But what about the veteran presence? Robert Stock just re-signed to a one-year deal. Is he a lock for the rotation?

Tom: Stock is a safety valve. He’s 36, earned his first MLB win since 2019, and knows how to navigate lineups. He’s not a long-term answer, but he’s insurance. If Manaea gets hurt or Megill struggles, Stock is ready to step in. It’s a smart, low-cost move by the front office to keep options open while they negotiate with Skubal.

Sarah: Smart, yes. Ambitious, definitely. Okay, let’s pivot to the infield. Chris from Queens asks: "Bo Bichette is listed at third base. Isn't that weird? He’s played shortstop his whole career. How does this work with Francisco Lindor at SS and Ronny Mauricio also at SS?"

Tom: It is unusual, but it speaks to the versatility the Mets are prioritizing. Bichette at third allows Lindor to stay at short, which is where he thrives defensively and offensively. Ronny Mauricio likely sees time at second base or as a utility guy, especially with Marcus Semien and Kyren Paris also in the mix. It creates a logjam, sure, but it also means you have four elite defenders who can play multiple positions.

Sarah: A logjam is fine if you have the depth to rotate them, but it means bench players are crucial. Does this affect Brett Baty? He’s been waiting for playing time at third. Now Bichette is there. Where does Baty go?

Tom: Baty probably moves around. He might see time at first base behind Mark Vientos or Christopher Morel, or he could be traded. The Mets have Jared Young and Mark Vientos at first, so Baty is squeezed. This is why the Eric Wagaman prediction we made last week feels even more likely—he’s getting moved to make room for these new talents.

Sarah: Alright, Segment Two. We’re talking roster battles. Jessica in Brooklyn asks: "Who wins the starting catcher job? Francisco Alvarez looks like a superstar, but Luis Torrens has experience. Hayden Senger is also on the roster. Who starts behind the plate?"

Tom: This is the most interesting battle on the team. Alvarez has the raw power and the defensive tools to be a future Hall of Famer, but Torrens brings veteran leadership and game-calling savvy. Senger is the backup option. My guess? They split time initially, but Alvarez will take the bulk of the reps as he develops his pitch framing. The offense is too good to bench.

Sarah: Exactly. You don’t sit Alvarez because he’s inexperienced. You coach him up. But what about the outfield? Juan Soto is listed at left field. That’s a huge upgrade for this team. Does that mean A.J. Ewing and Nick Morabito are fighting for the other spots?

Tom: Soto in left is a no-brainer. He’s one of the best hitters in the world. The real battle is center and right. Carson Benge is at right, and A.J. Ewing is at center. Morabito is likely the fourth outfielder. The defense in center needs to be solid, and Ewing has the speed, but Morabito’s bat might keep him in the lineup against lefties due to platoon splits.

Sarah: Platoon splits are key here. The Mets are building a lineup that can punish pitchers from both sides. With Soto, Lindor, Bichette, and Alvarez, the middle of the order is terrifying. But what about the bottom? Who’s hitting eighth and ninth? Ronny Mauricio and Marcus Semien seem like strong candidates.

Tom: Semien provides consistency and OBP, which is vital for setting up the heart of the order. Mauricio offers athleticism and upside. I’d expect Semien to get the nod early in the season because of his plate discipline, but Mauricio could steal the job if he hits his stride. It’s a competition that will last through April.

Sarah: And don’t forget, the next game is against the Miami Marlins on March 25th, 2027. So we have plenty of time to see these matchups develop. But before we get there, @PitchingNerd asks: "With all this movement, what happens to the minor league arms? Are any of them close to breaking through?"

Tom: That’s a great question. Names like Jack Anderson, Daniel Duarte, Reed Garrett, Justin Hagenman, Nate Lavender, Chayce McDermott, Tobias Myers, Dedniel Nunez, Pierson Ohl, Cionel Perez, Jonathan Pintaro, Dylan Ross, Austin Warren, Jack Weisenburger, and Jefry Yan are all in the system. Some are bullpen arms, some are starters. It’s a deep farm system, but none of them are imminent call-ups unless injuries strike. The major league club is full.

Sarah: Okay, Segment Three. Fun hypotheticals and lightning round. Mike in Manhattan asks: "If the Mets sign Tarik Skubal, what’s the best-case scenario for their 2027 season? Can they actually challenge the Braves?"

Tom: Best case? They win 95 games and make a deep playoff run. Adding Skubal to a rotation that already has Manaea and Megill gives them a top-three that can compete with Atlanta. The bullpen, with Williams and Senga, becomes a nightmare for opponents. If the offense stays healthy, this team is a legitimate World Series contender.

Sarah: That is bold. 95 wins. I love it. But let’s do a quick lightning round. First question: Who is the most underrated player on the current roster? Go.

Tom: Robert Stock. He’s keeping a spot open for a veteran arm that knows how to handle pressure. Plus, he’s been with the organization for a long time.

Sarah: Second question: What’s the biggest risk for the Mets this offseason? Go.

Tom: Overpaying for Skubal and limiting flexibility elsewhere. Or the infield logjam causing friction. Roster harmony matters.

Sarah: Third question: Final prediction for the NL East winner. Braves or Mets?

Tom: I’m sticking with my previous prediction: The Mets will win 86 games, but if they get Skubal, they surpass that. I think they edge out Atlanta because of the bullpen depth.

Sarah: There you have it. From Skubal meetings to infield logjams, the Mets are poised for a massive 2027. Before we go, I want to ask for your help. If these daily breakdowns are part of your morning routine or commute, a small tip is what keeps us bringing you free, unbiased analysis every single day. Please consider chipping in via the link in the episode description.

Tom: We appreciate every listener who supports the show. It helps us keep digging into the stats and bringing you the best coverage possible. Thank you for listening.

Sarah: Don’t forget to subscribe, rate, and review wherever you listen. Share this episode with a fellow Mets fan. Until next time, keep your eyes on the scoreboard and your faith in the team. Go Mets!